Skip to main content

Peripheral Neuropathy and cannabis in Utah

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
Up to 30-day supply (11…
POSSESSION
$15/yr
STATE FEE
7–21 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Utah statute and program

The Utah Medical Cannabis Program is the operating authority for Utah patient certification. The authoritative legal text is: Utah Code Title 26B Chapter 4: Medical Cannabis Act (Prop 2 of 2018 + HB 3001).

What the evidence says about cannabis and Peripheral Neuropathy

Peripheral neuropathy is damage to or dysfunction of the peripheral nervous system (nerves outside the brain and spinal cord). Common causes include diabetes mellitus, chemotherapy, HIV infection, alcohol use, autoimmune disease, vitamin deficiency, infection, trauma, and inherited disorders. Symptoms typically include burning or shooting pain, tingling, numbness, weakness, and loss of coordination, most often in a stocking-glove distribution affecting feet first and then hands.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Peripheral Neuropathy page.

How to qualify in Utah

The Utah Medical Cannabis Program requires the following registration steps for a Peripheral Neuropathy patient (or any qualifying diagnosis):

  1. See a Qualified Medical Provider (QMP) registered with Utah DHHS. Under Utah Code §26B-4-201 et seq. (Utah Medical Cannabis Act, Prop 2 of 2018 as amended by HB 3001), only Qualified Medical Providers (QMPs) — Utah-licensed physicians, advanced practice registered nurses, physician assistants, and podiatrists who have completed the 4-hour Utah DHHS qualifying course and registered with the Center for Medical Cannabis — may certify a patient. Qualifying conditions include cancer, HIV/AIDS, ALS, cachexia, persistent nausea, Crohn’s, epilepsy, MS, PTSD, autism, Alzheimer’s, terminal illness, and chronic pain (with strict opioid-alternative documentation).
  2. Apply through the Utah Medical Cannabis Program portal (EVS). The QMP issues the medical cannabis recommendation through the Utah Department of Health and Human Services Electronic Verification System (EVS). The patient then completes the patient registration in EVS with a Utah driver license or state ID and a passport-style photograph.
  3. Pay the $15 state registration fee (or $5 for renewal). The initial Utah medical cannabis patient card fee is $15 (6-month card for the first issuance), renewable at $5. Patients aged 65 and older, terminal patients, and patients with documented hospice care are exempt from the registration fee. The QMP also charges a separate evaluation fee.
  4. Receive the card and purchase from a Utah pharmacy. Utah medical cannabis patient cards are issued within roughly 14 business days of complete application. With the card, patients may purchase up to a 30-day supply (based on QMP-set dosing) from any of the 15 licensed Utah medical cannabis pharmacies. Permitted forms include flower (added 2020), edibles in tablet/capsule/lozenge form only (no gummies or candy-like products), vape products, tinctures, topicals, and concentrates. Utah does not honor out-of-state medical cards.
State registration fee
$15
Physician visit (typical)
$150–$300
Certification to card
7–21 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Utah registration steps, fees, and reciprocity rules, see the Utah cannabis-laws page.

ICD-10 code

A certifying physician documenting Peripheral Neuropathy for the Utah medical cannabis program will typically record ICD-10 G62.9 or SNOMED-CT 42658009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Utah list Peripheral Neuropathy as a qualifying condition for medical cannabis?

No. Utah's qualifying-condition list does not currently include Peripheral Neuropathy, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Peripheral Neuropathy in Utah have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Utah program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a Utah medical marijuana card for Peripheral Neuropathy?

Because Utah does not currently list Peripheral Neuropathy as a qualifying condition, a card for Peripheral Neuropathy alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Utah who is registered with Utah Medical Cannabis Program and willing to evaluate Peripheral Neuropathy cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Utah does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Peripheral Neuropathy?

For Peripheral Neuropathy, evidence is described as moderate (supportive controlled studies exist but the picture is mixed). The mmjnow condition page for Peripheral Neuropathy lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Peripheral Neuropathy should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Peripheral Neuropathy and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Peripheral Neuropathy; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Utah Code Title 26B Chapter 4: Medical Cannabis Act (Prop 2 of 2018 + HB 3001)accessed May 16, 2026
  2. Utah Department of Health and Human Services: Center for Medical Cannabisaccessed May 16, 2026
  3. Wikipedia: Cannabis in Utahaccessed May 16, 2026
  4. Utah Code Title 58 Chapter 37: Utah Controlled Substances Act (possession penalty schedule)accessed May 18, 2026
  5. Utah Department of Agriculture & Food: Industrial Hemp Programaccessed May 18, 2026
  6. Utah State Legislature bill trackeraccessed May 18, 2026
  7. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 16, 2026

    “Substantial evidence that cannabis is an effective treatment for chronic pain in adults.”

  8. NIH NINDS: Peripheral Neuropathyaccessed May 16, 2026